scholarly journals Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis

Tuberculosis ◽  
2014 ◽  
Vol 94 (3) ◽  
pp. 187-196 ◽  
Author(s):  
Payam Nahid ◽  
Erin Bliven-Sizemore ◽  
Leah G. Jarlsberg ◽  
Mary A. De Groote ◽  
John L. Johnson ◽  
...  
2017 ◽  
Vol 74 (4) ◽  
pp. 367-376 ◽  
Author(s):  
Nicola M. Zetola ◽  
Chawangwa Modongo ◽  
Ogopotse Matsiri ◽  
Tsaone Tamuhla ◽  
Bontle Mbongwe ◽  
...  

PLoS Medicine ◽  
2019 ◽  
Vol 16 (4) ◽  
pp. e1002780 ◽  
Author(s):  
Masanori Kawasaki ◽  
Carmenchu Echiverri ◽  
Lawrence Raymond ◽  
Elizabeth Cadena ◽  
Evelyn Reside ◽  
...  

2007 ◽  
Vol 45 (4) ◽  
pp. 428-435 ◽  
Author(s):  
B. Alisjahbana ◽  
E. Sahiratmadja ◽  
E. J. Nelwan ◽  
A. M. Purwa ◽  
Y. Ahmad ◽  
...  

2012 ◽  
Vol 206 (7) ◽  
pp. 1030-1040 ◽  
Author(s):  
S. E. Dorman ◽  
S. Goldberg ◽  
J. E. Stout ◽  
G. Muzanyi ◽  
J. L. Johnson ◽  
...  

2009 ◽  
Vol 180 (3) ◽  
pp. 273-280 ◽  
Author(s):  
Susan E. Dorman ◽  
John L. Johnson ◽  
Stefan Goldberg ◽  
Grace Muzanye ◽  
Nesri Padayatchi ◽  
...  

2019 ◽  
Vol 38 (4) ◽  
pp. 232-8
Author(s):  
Risa Fitria ◽  
Feni Fitriani Taufik ◽  
Dewi Behtri Yanifitri

Background: Many diseases are associated with smoking such as malignant disease, cardiovascular, diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), arthritis, impotence, infertility, Alzheimer’s Disease, tuberculosis and others. Smoking is proven to disrupt the ciliary mucosal clearance and it is associated with an increased risk of pulmonary tuberculosis. Sputum conversion is an important indicator to assess the success of TB treatment. This study aims to determine the relation between smoking history and the success intensive phase treatment of pulmonary tuberculosis at Dr Zainoel Abidin Hospital. Method: Prospective cohort study in patients with pulmonary tuberculosis acid-fast bacilli (AFB) positive (+) smokers and non smokers who visited the Integrated Tuberculosis Care (PTT), at outpatient and inpatient pulmonary infection RSU Dr. Zainoel Abidin hospital Banda Aceh from 28 November 2015 until 1 February 2016. Results: A total of 38 subjects were divided into 2 groups (19 subjects with 19 subjects smokers and non-smokers). All subjects smokers are male while nonsmoker subjects consisted of male and female. The results of the first month study (p=0.009), there are 14 non smoker subjects with AFB conversion (73,7%) and 5 subjetcs without AFB conversion. Among smoking subjects there are 6 subjets (31.6%) with AFB conversion and 13 subjects (68.4% ) without AFB conversion. In the second month (p=0,202), more than half subjects who are non-smokers had AFB conversion, 17 subjects (89.5%) and 2 subjects (10.5%) had no AFB conversion. In smokers group there are 14 subjects (73.7% ) had AFB conversion and 5 subject (26.3%) had no conversion. Conclusion: There was a significant relation between smoking habit and the occurrence of first-month AFB sputum. (J Respir Indo. 2018; 38: 232-8)


2015 ◽  
Vol 2 (suppl_1) ◽  
Author(s):  
In Young Jung ◽  
Mi-Young Ahn ◽  
Yong Duk Jeon ◽  
Hae Won Ahn ◽  
Jin Young Ahn ◽  
...  

2021 ◽  
pp. 15-19
Author(s):  
Vasyl Kushnir

Despite the availability of medical services, timely detection of pulmonary tuberculosis, before the appearance of destructive changes, is often difficult. The management of patients with an infiltrative form in a hospital setting does not always guarantee the same positive effect and sometimes requires prolongation of therapy. The effectiveness of therapy can be associated with various factors and is of interest to study. The aim of this work was to study the effectiveness of standard therapy in patients with first diagnosed infiltrative pulmonary tuberculosis, clinical laboratory and radiological associations with prolongation of the intensive phase of treatment. Materials and methods. The study involved 109 men from 18 to 53 years old with first diagnosed infiltrative pulmonary tuberculosis with preserved MBT sensitivity to 1-st line anti-tuberculosis drugs. Patients were examined before and after 60 doses of the intensive phase of treatment, after which two groups were formed. Group 1 included patients with pronounced positive clinical and radiological dynamics, who entered the continuation phase of therapy. Group 2 included patients with insufficient clinical and radiological dynamics, for whom the intensive phase of treatment was extended to 90 doses. Results. Weak dynamics in patients who needed prolongation of treatment was associated with the characteristics of the initial data of patients in this group compared with similar indicators in Group 1. These were a reliably higher frequency of symptoms of intoxication and coughing, a reliably greater number of patients excreting mycobacterium tuberculosis in large quantities in sputum, with reliably high blood concentrations of haptoglobin and ceruloplasmin levels. Conclusions. Patients requiring prolongation of the intensive phase of treatment are characterized by an initially higher prevalence of infiltrative changes in the lungs, a small number of lung lesions limited to 2 segments, the presence of destructive changes in 100 % of cases, and a significant increase in the factors of the systemic inflammatory response


Sign in / Sign up

Export Citation Format

Share Document